LB Pharmaceuticals Inc (LBRX) News
Follow LB Pharmaceuticals Inc (LBRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Susan G. Kozauer named Chief Medical Officer at LB Pharmaceuticals
LB Pharmaceuticals appointed Susan G. Kozauer as Chief Medical Officer, effective September 14, 2026.Original SEC Filing: LB PHARMACEUTICALS INC [ LBRX ] - 8-K - Sep. 15, 2026This is an AI-powered summary. It may contain
REGULATION | Sep 15, 2026, 12:14 PM UTC
L
LB Pharmaceuticals Inc (NASDAQ:LBRX) Appoints Susan G. Kozauer, M.D. as CMO
LB Pharmaceuticals Inc named Susan G. Kozauer, M.D. as Chief Medical Officer. The company highlighted her late-stage neuropsychiatric drug development experience ahead of its Phase 3 NOVA-2 schizophrenia readout expected
NEWS | Sep 15, 2026, 12:04 PM UTC
L
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) NASDAQ:LBRX, a neuromedicines company dedicated to developing and commercializing high-impact therapies that add
NEWS | Sep 15, 2026, 12:03 PM UTC
L
LBRX - LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
LBRX - LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
NEWS | Sep 15, 2026, 12:00 PM UTC
L
LB Pharmaceuticals to participate in September investor events
LB Pharmaceuticals Inc (LBRX) said it will participate in upcoming September investor events, according to a GlobeNewswire announcement.
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
LBRX - LB Pharmaceuticals to Participate in Upcoming September Investor Events
LBRX - LB Pharmaceuticals to Participate in Upcoming September Investor Events
EQUITY | Sep 03, 2026, 08:05 PM UTC
L
LB Pharmaceuticals hires Joseph Miller as chief financial officer
LB Pharmaceuticals hired Joseph Miller as its new chief financial officer. Miller, 52, most recently served as finance chief of Aurinia Pharmaceuticals.
EQUITY | Sep 03, 2026, 12:43 PM UTC
L
LB appoints Joseph M. Miller as chief financial officer
LB appointed Joseph M. Miller as chief financial officer, effective September 2, 2026, according to its 8-K filing.
REGULATION | Sep 03, 2026, 12:13 PM UTC
L
LB Pharmaceuticals appoints Joseph Miller as chief financial officer
LB Pharmaceuticals Inc said it appointed Joseph Miller as its chief financial officer. The neuromedicines company focuses on developing and commercializing therapies for underserved brain disorders.
EQUITY | Sep 03, 2026, 12:07 PM UTC
L
LBRX appoints Joseph Miller as Chief Financial Officer
LBRX appointed Joseph Miller as Chief Financial Officer.
EQUITY | Sep 03, 2026, 12:00 PM UTC
H
LBRX Has Multi-Blockbuster Potential
LBRX has multi-blockbuster potential
EQUITY | Aug 03, 2026, 01:04 PM UTC
H
LBRX Raises $150M
LBRX raises $150M in PIPE
EQUITY | Jul 29, 2026, 12:02 PM UTC
H
LBRX Announces $150M Private Placement
LBRX raises $150 million in private placement
EQUITY | Jul 29, 2026, 12:00 PM UTC